A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Diazoxide Choline Controlled-Release Tablet (DCCR) in Subjects Without Diabetes Mellitus Having Very High Fasting Triglyceride Levels, With Double-Blind DCCR-Fenofibrate Combination Extension

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Diazoxide Choline Controlled-Release Tablet (DCCR) in Subjects Without Diabetes Mellitus Having Very High Fasting Triglyceride Levels, With Double-Blind DCCR-Fenofibrate Combination Extension

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Jan 2014

At a glance

  • Drugs Diazoxide (Primary) ; Atorvastatin; Fenofibrate
  • Indications Hypertriglyceridaemia
  • Focus Therapeutic Use
  • Sponsors Essentialis
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Jan 2014 Last checked against ClinicalTrials.gov record.
    • 01 Mar 2012 Primary endpoint 'Triglyceride-levels' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top